PA-TU-8988T Cells

SKU:BHC10902260
—
Suppliers
Applied Biological Materials (abm) Inc.
Applied Biological Materials (abm) Inc.
Details Products
Overview
Click light‑blue chips for details
PA-TU-8988T Cells is supplied as frozen tumor cell line. Commonly used in cell biology, phenotype comparison, and assay development under defined culture conditions.
Cell Type Cell Lines, Tumor Cell Lines
Options selector
Catalog no. Pack Size
T1295 1x106 cells / 1.0 ml
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Pack Size: 1x106 cells / 1.0 ml
  • Lead time: varies by selected option; please contact us for current fulfillment timing.
  • Storage: Refer to the product datasheet for storage and handling.
  • Shipping: see shipping details at checkout.
  • Upon receipt: follow the product datasheet storage instructions.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Applications
  • Cell Culture (Growth)
  • Immunophenotyping
  • Flow Cytometry
Catalog no. (Mfr.) T1295
Main SKU BHC10902260

Overview

PA-TU-8988T Cells is a tumor cell line supplied in cell format.

Key elements and design rationale

  • Model identity: PA-TU-8988T Cells is supplied as a tumor cell line.

This cell-based model is generally used in cell biology, phenotype comparison, and assay development studies.

Biological background

This model supports studies in cell biology, phenotype comparison, and assay development. It can be used to examine morphology, growth behavior, and experimental responses in cultured cells.

Research relevance and current trends

  • Cell-line models continue to be used for tumor phenotype comparison, pathway perturbation studies, and assay development in controlled in vitro systems.
  • Engineered and subtype-defined tumor lines are often used to compare growth behavior, reporter output, and response patterns across matched experimental conditions.
  • When metastatic or lineage features are described, investigators commonly interpret results alongside morphology, passage history, and culture environment.

Common research applications

  • Cancer biology studies that compare proliferation-associated behavior, morphology, and pathway responses in vitro.
  • Assay development for treatment response, reporter monitoring, or phenotype comparison under matched culture conditions.
  • Side-by-side comparison of engineered versus parental background characteristics when relevant to the study design.

Changes in morphology, growth rate, viability, or reporter signal are typically interpreted together with passage history, culture matrix, and the specified growth conditions for the model.

Notes for experimental interpretation

  • Morphology, doubling behavior, and reporter or marker output can shift with passage number, substrate choice, and medium composition; these variables should be recorded alongside experimental readouts.
  • Matched controls such as parental cells, untreated cultures, or parallel cultures maintained under identical conditions help distinguish background effects from biology of interest.

Material Citation: If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. T1295

How should I handle live cells once I receive them?
Please refer to our Cell Handling and Thawing Guidelines for detailed instructions on receiving, thawing, and culturing live cells:
https://www.abmgood.com/immortalized-cells-documents.html
Following these guidelines will help ensure optimal cell viability and performance.
Why are these cells classified as biosafety level II?
We follow the CDC-NIH recommendations that all mammalian sourced products should be handled at the Biological Safety Level 2 to minimize exposure of potentially infectious products. This information can be found in 'Biosafety in Microbiological and Biomedical Laboratories' (1999). Your institution's Safety Officer or Technical Services will be able to make the call as to whether BioSafety Level I is possible with these cells at your site, if desired.
What is your warranty or return policy?
Our warranty and return policy is outlined in abm’s Terms and Conditions, including details on product quality, limitations, and claims.
Please refer to the following link for full information:
https://www.abmgood.com/terms
For additional questions, our Order team is happy to assist and can be reached at order@abmgood.com.
How many times can cells divide?
The number of times cells can divide depends on the cell type:

Primary cells have a limited lifespan and will undergo a finite number of population doublings before entering senescence. The exact number varies by cell type and culture conditions.
Immortalized cell lines are capable of extended or indefinite proliferation under proper culture conditions, although growth characteristics may vary between lines.
Do I need Applied Cell Extracellular Matrix (G422) if I am using PriCoat™ flasks?
Please refer to the Growth Conditions section of your specific product page. This section will indicate whether Applied Cell Extracellular Matrix (G422), PriCoat™ flasks, or both are recommended for optimal cell attachment and growth, as requirements may vary by cell type.

Cell line sourcing and selection (species, tissue, and disease model matching) · Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA) · Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs) · Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles) · Inducible expression systems (Tet-On/Off and regulatable constructs) · Drug resistance marker selection (puromycin, G418, hygromycin, and others) · Custom growth and media optimisation for specific assay requirements · Scale-up production for high-throughput screening campaigns · Authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Talk to a Scientist or contact support@biohippo.com.

Elsasser H.P., Lehr U., Agricola B. and Kern H.F. (1992) Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Archiv 61(5): 295-306. http://www.ncbi.nlm.nih.gov/pubmed/1348891

Hamidi H, Lu M, Chau K, Anderson L, Fejzo M, Ginther C, Linnartz R, Zubel A, Slamon DJ and Finn RS (2014) KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.. British journal of cancer 111(9): 1788-801. http://www.ncbi.nlm.nih.gov/pubmed/25167228

Miquel M, Zhang S and Pilarsky C (2021) Pre-clinical Models of Metastasis in Pancreatic Cancer.. Frontiers in cell and developmental biology 9: 748631. http://www.ncbi.nlm.nih.gov/pubmed/34778259

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today